The independent source for health policy research, polling, and news.
41 - 60 of 112,236 Results
Politico reports that Marty Makary’s time leading the FDA saw mass layoffs, ongoing churn among senior leaders, and policy fights. Meanwhile, Fox News reports that the FDA has approved the first-ever non-antipsychotic drug treatment for agitation in Alzheimer’s disease patients.
Minnesota is monitoring a resident who might have been exposed to the virus by a passenger of the MV Hondius, while Illinois health officials are investigating a potential case that they don't think is related to the cruise ship outbreak. Meanwhile, a mishmash of strategies to stop the spread is complicating the global response to the outbreak.
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health topics.
The makers of these heath trackers hope to incorporate AI to predict future ailments such as heart attack, stroke, and dementia, Bloomberg reports. Also: GLP-1s might reduce risk of macular degeneration; NAD+ supplement use is booming; and more.
Some states are contemplating the use of AI to determine eligibility of Medicaid work requirements under President Donald Trump’s tax law. More than 40 health organizations have participated in the feedback process to establish CHAI's proposed standards and guardrails for AI use, Modern Healthcare reports.
President Donald Trump will head to Walter Reed National Military Medical Center on May 26, the AP reports, for what the White House says is an annual physical and regular preventive care. Also in the news: vaccines, FDA leadership, and fruit-flavored vapes.
Fierce Healthcare reports on the American Medical Association's new framework for doctor identity protections. Also in public health news: alcohol addiction, suicide prevention, tick bites, and more.
The court has until Thursday to determine the legality of telemedicine access to the abortion pill mifepristone. In the meantime, mifepristone may still be prescribed online and distributed by mail, NPR reports. Also in the news: fertility treatment coverage rules; PCOS' renaming; and more.
MedPage Today reports on the relocation of the American passenger and their partner from quarantine at the University of Nebraska Medical Center in Omaha to Emory University in Atlanta after the person developed symptoms. The Trump administration's response to the virus and the search for treatments are also in the news.
Today's early morning highlights from the major news organizations.
Opinion writers discuss these public health topics.
New guidance from the American Academy of Pediatrics touts the physical, emotional, and academic benefits of recess for kids of all ages, the AP reports. The group also recommends that recess should not only be protected but also not withheld for academic or punitive reasons, as sometimes happens.
STAT reports how Leqembi and Kisunla, the recently approved Alzheimer's drugs, have had low uptake from those in need due to how hard they are to administer and their potential for severe side effects like brain bleeding. Also in the news: a pacemaker recall; a new cancer treatment; miniature therapy horses; and more.
WLRN Public Media covers findings from the UnidosUS report, including that more than 4 million Latinos are projected to lose health insurance in the coming decade because of the cuts.
The site, which launched on Mother's Day, is aimed at assisting women who find themselves experiencing an unexpected pregnancy. Also: estrogen patch shortages; Florida's six-week abortion ban; and more.
A plane carrying 17 Americans and one British national who lives in the U.S. landed in Omaha early Monday. The passengers were taken to the University of Nebraska Medical Center; the person who tested "weak positive" will be taken to the biocontainment unit, CNN reported. A second U.S. passenger was showing mild symptoms but tested negative, health officials said.
On Friday, news outlets reported that FDA commissioner Marty Makary was about to be fired. President Donald Trump said, "I know nothing about it," and the White House did not comment. While Makary's fate is up in the air, Axios reports that a potential replacement would likely be a more traditional pick than the current MAHA advocate.
Today's early morning highlights from the major news organizations.
Opinion writers discuss these public health topics.
© 2026 KFF